Steven Itzkowitz, MD, FACP, FACG, AGAF

Itzkowitz

Mount Sinai

C5 Coalition

Steering Committee Member

Dr. Itzkowitz is Professor of Medicine and Oncological Sciences and Director of the GI Fellowship Program at Icahn School of Medicine at Mount Sinai. Dr. Itzkowitz is past Chair of the Gastrointestinal Oncology Section of the American Gastroenterological Association and immediate past Co-Chair of the New York Citywide Colon Cancer Control Coalition (“C5 Coalition”). He is the founder and Medical Director of the Mount Sinai CO-CARE Registry for patients and their relatives who are at high risk of colon cancer. His research has focused on reducing disparities in colon cancer screening in the general population, developing new non-invasive stool DNA tests to screen for colon cancer, and detecting and preventing colon cancer in inflammatory bowel disease.

Heather Hampel, MS, CGCC

Hampel

National Society of Genetic Counselors

Steering Committee Member

Heather Hampel completed her Bachelor of Science degree in Molecular Genetics at the Ohio State University in 1993. She attained her master’s degree in Human Genetics from Sarah Lawrence College in 1995. She received certification from the American Board of Genetic Counseling in 1996. She worked as a cancer genetic counselor at Memorial Sloan- Kettering Cancer Center in Manhattan before moving to The Ohio State University in 1997.

Since January of 2015, Heather has been the associate director for biospecimen research for The Ohio State University Comprehensive Cancer Center (OSUCCC). In this role, Heather is responsible for supporting biospecimen research within the OSUCCC. Specifically, she provides oversight and coordination of all OSUCCC biospecimen activities and infrastructure. She also provides consultation to faculty and staff wanting to use OSUCCC biospecimens, including navigating the application process, understanding IRB requirements and selecting samples. In addition, Heather provides internal training and consultation to members on the use of biospecimens relevant to biomarkers, personalized medicine and genetics.

Heather is a Professor in the Department of Internal Medicine and Associate Director of the Division of Human Genetics. She is the PI of both the Total Cancer Care® (TCC) protocol and the Ohio Colon Cancer Prevention Initiative (OCCPI). Heather is an internationally recognized cancer genetic counselor with a particular emphasis on universal tumor screening for Lynch syndrome. Her research interests include screening all colorectal and endometrial cancer patients for Lynch syndrome. This work has led to changes in standard-of-care genetic screening practices in colon cancer patients. Heather was on the Board of Directors of the National Society of Genetic Counselors from 2003-2004 and of the American Board of Genetic Counseling from 2006-2011, serving as President in 2009 and 2010. She was an elected Council member of the Collaborative Group of the Americas on Inherited Colorectal Cancer in 2016 and is President-elect in 2017. She was elected to the Steering Committee of the National Colorectal Cancer Roundtable in November of 2016.

Paul Schroy, MD, MPH

Dr. Schroy is a graduate of Haverford College, Jefferson Medical School and the Boston University School of Public Health. He completed his residency in Internal Medicine at the North Shore University Hospital (Cornell University) and fellowship in Gastroenterology at the Memorial Sloan-Kettering Cancer Center. Dr. Schroy is a Professor of Medicine at the Boston University School of Medicine and Director of Clinical Research for the Section of Gastroenterology at Boston Medical Center. He is the recipient of a number of grants to support his research in the area of colorectal cancer screening and prevention. His current research interests focus on the role of shared decision-making and risk stratification as strategies for increasing patient participation in colorectal cancer screening, the epidemiology of colorectal neoplasia, the feasibility and validity of novel colorectal cancer screening approaches such as stool-based DNA testing and virtual colonoscopy, and quality issues related to colorectal cancer screening.

In addition to his commitment to patient care and clinical research, Dr. Schroy is a founding member and former chair of the Massachusetts Colorectal Cancer Working Group and former member of the Steering Committee of the National Colorectal Cancer Roundtable. He has served in numerous leadership positions for the Roundtable, including current co-chair of the Family History and Early Onset Colorectal Cancer Task Group, former co-chair of the Public Education Task Group, former co-chair of the Screening 65+ Task Group, and former chair of the Nomination Committee. He is also a member of the American Cancer Society, New England Division’s Colorectal Cancer Advisory Committee and the Massachusetts Department of Public Health’s Cancer Registry Advisory Committee.